Aparna Ahuja - Feb 20, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Medical Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 20, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 05:28 PM
Previous filing
Jan 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +600K $0.00 600K Feb 20, 2022 Common Stock 600K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units vest in three equal annual installments commencing on February 20, 2023.